← Open Payments lookup

CHARLES BROWN: Open Payments

NPI 1487803003 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,340 in 61 payments from 15 companies in 2025. Trend: 2023 $1,137 · 2024 $1,620 · 2025 $1,340

Food & beverage: $1,274Education: $66
CompanyPaymentsAmount
Janssen Biotech, Inc.12$299
ABBVIE INC.12$203
LEO Pharma Inc.6$118
GENZYME CORPORATION3$114
UCB, Inc.3$96
PFIZER INC.5$95
Regeneron Healthcare Solutions, Inc.3$81
Novartis Pharmaceuticals Corporation3$77
Incyte Corporation3$68
Amgen Inc.4$67

Products named: TREMFYA, DUPIXENT, RINVOQ, SKYRIZI, Bimzelx, CIBINQO, OPZELURA, OTEZLA.

Industry payments across MD — which companies pay providers there.